These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36087906)

  • 1. Pretomanid development and its clinical roles in treating tuberculosis.
    Fekadu G; Tolossa T; Turi E; Bekele F; Fetensa G
    J Glob Antimicrob Resist; 2022 Dec; 31():175-184. PubMed ID: 36087906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic investigational new drugs for the treatment of tuberculosis.
    Kwon YS; Koh WJ
    Expert Opin Investig Drugs; 2016; 25(2):183-93. PubMed ID: 26576631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling Dilemmas and Lacunae in the Escalating Drug Resistance of
    Negi A; Perveen S; Gupta R; Singh PP; Sharma R
    J Med Chem; 2024 Feb; 67(4):2264-2286. PubMed ID: 38351709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis.
    Wen S; Jing W; Zhang T; Zong Z; Xue Y; Shang Y; Wang F; Huang H; Chu N; Pang Y
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1293-1296. PubMed ID: 30953211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
    Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
    Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delamanid or pretomanid? A Solomonic judgement!
    Mudde SE; Upton AM; Lenaerts A; Bax HI; De Steenwinkel JEM
    J Antimicrob Chemother; 2022 Mar; 77(4):880-902. PubMed ID: 35089314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice.
    Nguyen TVA; Nguyen QH; Nguyen TNT; Anthony RM; Vu DH; Alffenaar JC
    Int J Antimicrob Agents; 2023 Oct; 62(4):106953. PubMed ID: 37595848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date.
    Stancil SL; Mirzayev F; Abdel-Rahman SM
    Drug Des Devel Ther; 2021; 15():2815-2830. PubMed ID: 34234413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretomanid for the treatment of pulmonary tuberculosis.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2020 Oct; 56(10):655-668. PubMed ID: 33185630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretomanid for tuberculosis: a systematic review.
    Gils T; Lynen L; de Jong BC; Van Deun A; Decroo T
    Clin Microbiol Infect; 2022 Jan; 28(1):31-42. PubMed ID: 34400340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretomanid: The latest USFDA-approved anti-tuberculosis drug.
    Deb U; Biswas S
    Indian J Tuberc; 2021 Apr; 68(2):287-291. PubMed ID: 33845969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model.
    Li SY; Converse PJ; Betoudji F; Lee J; Mdluli K; Upton A; Fotouhi N; Nuermberger EL
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0003523. PubMed ID: 36920217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
    Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
    Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic
    Mota F; Ruiz-Bedoya CA; Tucker EW; Holt DP; De Jesus P; Lodge MA; Erice C; Chen X; Bahr M; Flavahan K; Kim J; Brosnan MK; Ordonez AA; Peloquin CA; Dannals RF; Jain SK
    Nat Commun; 2022 Dec; 13(1):7974. PubMed ID: 36581633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretomanid: First Approval.
    Keam SJ
    Drugs; 2019 Nov; 79(16):1797-1803. PubMed ID: 31583606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Drugs for the Treatment of Tuberculosis.
    Ignatius EH; Dooley KE
    Clin Chest Med; 2019 Dec; 40(4):811-827. PubMed ID: 31731986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretomanid: A novel therapeutic paradigm for treatment of drug resistant tuberculosis.
    Parveen U; Sultana S; Heba SF; Rafi R; Begum A; Fatima N
    Indian J Tuberc; 2021 Jan; 68(1):106-113. PubMed ID: 33641829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.
    Furin J; Brigden G; Lessem E; Rich M; Vaughan L; Lynch S
    Emerg Infect Dis; 2016 Mar; 22(3):. PubMed ID: 26885674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
    Blair HA; Scott LJ
    Drugs; 2015 Jan; 75(1):91-100. PubMed ID: 25404020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.